Biotech1 day ago
DeepUll Secures €50M to Revolutionize Sepsis Diagnosis with Rapid Test
Barcelona-based DeepUll raised €50 million in Series C funding to validate UllCORE, a rapid sepsis diagnostic tool. The test identifies 95% of sepsis pathogens within an...